Although plasma norepinephrine (NE) increases with age in response to a variety of submaximal adrenergic stimuli, the effect of age on plasma catecholamine levels during maximal aerobic effort and during submaximal work at a fixed percent of peak O2 consumption (VO2) is unknown. We therefore measured NE, epinephrine (E), and VO2 at rest and during graded maximal treadmill exercise in 24 healthy male volunteers (ages 22-77 yr) from the Baltimore Longitudinal Study of Aging who were rigorously screened to exclude the presence of cardiovascular disease. At rest neither heart rate (HR) nor VO2 were age related. Resting NE (pg/ml) was not age related, but resting E (pg/ml) was higher in male subjects 68-77 yr old (group III) than in those aged 22-37 (group I) or 44-55 yr (group II), P less than 0.01. Maximal HR (beats/min) showed a strong inverse relationship to age (203.5 - 0.65 age, r = -0.80, P less than 0.001). Peak VO2 in milliliters per kilogram total body weight per minute decreased with age (47.7 - 0.23 age, r = -0.71, P less than 0.001). At maximal effort both NE (P less than 0.01) and E (P less than 0.05) were higher in group III than in either of the younger groups. At submaximal work levels NE and E also increased with age, and when normalized for relative effort at loads between 45 and 80% of peak VO2 both NE and E were higher in the group III male subjects, although statistical significance was reached for NE (P less than 0.01) but not for E (P = 0.09).(ABSTRACT TRUNCATED AT 250 WORDS)
The physiological adjustments to aerobic work (5.6 km/h, up a 9% grade) and to exhausting treadmill work of former champion middle-distance runners were determined in 1971, at ages 47-68 yr, 25-43 yr after their competitive careers in track. In the resting state the former athletes as a group are very much like nonathletes of the same ages. Efficiency in the aerobic walk was the same in both groups and did not change with age in either, but the former athletes on the average performed the walk with less strain as indicated by lower blood lactates, "ventilatory equivalents," and heart rates than nonathletes at corresponding ages. Mean VO2max of the runners declined from 71.4 ml/min-kg-1 in youth to 41.8 at a mean age of 56.6 yr, as compared with mean values of 50.6 and 36.5 ml/min-kg-1 in nonathletes at corresponding ages. VO2max had declined below the average of nonathletic men in only two of the former runners. Mean maximal heart rate declined with age from 186 to 180 in the runners, and from 199 to 186 in nonathletes at corresponding ages. Ventilatory responses of men in both groups were closely related to the increases of blood lactate in both aerobic and maximal work.
The physiological adjustments of the men to both aerobic (5.6 km/h, up 9% grade), and maximal treadmill work were first determined when they were healthy college students, ages 18-22 yr. They were restudied at ages 40-44, and again at ages 49-53 yr. In the aerobic walk VO2 increased in proportion to weight gain, but efficiency did not change with age. The men who had gained most weight showed the greatest elevations of heart rate, blood lactate and "ventilatory equivalent," and reductions of the "O2 pulse" in the walk. At age 50 mean "O2 pulse" in exhausting work had declined 13%, even though mean maximal heart rate had declined 15 beats/min from values observed in youth. At ages 40-44 yr mean VO2 max had declined 25% to values 12% lower than mean values reported in 1938 for men of this age. Eight of the men imporved an average of 11% in VO2 max between ages 40-44 and 49-53 yr; mean VO2 max of the others continued to decline with age. The five men who improved most had increased their participation in vigorous activities (tennis, squash, skiing, jogging, etc.) and had quit or reduced their smoking.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.